This course is updated regularly as new practice guidelines are developed.This course will equip clinicians to evaluate the needs for medical treatment for their psychotherapy clients, to assess responses to treatment and to more effectively collaborate with primary care physicians and psychiatrists.In addition, there will be brief mention of neurobiology and pathophysiology associated with certain clinical conditions, although a comprehensive discussion of these topics is beyond the scope of this course (see J. 2003 and Preston, et al., 2017 for a more detailed review).The primary focus of this course is to provide a current overview of psychopharmacologic treatment guidelines. Net is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Net maintains responsibility for this program and its content. Net, provider #1107, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) org, through the Approved Continuing Education (ACE) program. Programs that do not qualify for NBCC credit are clearly identified. Net is solely responsible for all aspects of the programs. Net is approved by the Ohio Counselor, Social Worker, & Marriage and Family Therapist Board (OH-CSWMFT) to offer continuing education for counselors, social workers, and MFTs. The materials in this course are based on the most accurate information available to the author at the time of writing. Course format (distance learning - online activity). Net has been approved by the National Board for Certified Counselors (NBCC) as an Approved Continuing Education Provider (ACEP), ACEP #6323.The effect is that they can take a “typical” starting dose of a medication, and on its trip through the liver, only small amounts are transformed and excreted.
How rapidly the liver metabolizes drugs depends on a number of factors.An assumption is made that you are very familiar with psychopathology and DSM diagnostic criteria, however there will be supplemental diagnostic information presented in this course as it applies to treatment decision making.More recent epidemiological studies and new findings in the neurosciences have influenced changes in some diagnostic criteria in the DSM-5 which will be addressed in this course.This resulting blood level is what matters when it comes to reducing symptoms.(Note: two psychotropic medications are not metabolized in the liver: lithium and Neurontin). A small percentage of people are known as rapid metabolizers.It is clear from the existing case law that it is unethical and illegal to tell patients either: 1. This is a significant problem and psychotherapists can provide enormous help to patients by monitoring their medication treatment and providing support and information regarding drug treatments, and be able to do so in ethical and legal ways. For each psychiatric medication discussed in this text, you will see listed the typical adult daily doses.In many instances the “therapeutic dosage range” is broad. It is important to know that the amount of medication required to effectively reduce and eliminate symptoms often has little to do with how severe the symptoms are.The ultimate solution for hypo-metabolizers thus is to use very small doses of medications initially and then increase doses gradually.Sometimes when a person is first treated they will experience serious side effects and this may be due to hypo-metabolizing.Here the drug molecules are acted upon by liver enzymes that begin a process generally referred to as biotransformation.Liver enzymes chemically alter the medication in ways that allow the drug to be more readily excreted from the body. Thus, in this so-called “first pass effect” through the liver, a good deal of the drug is chemically transformed and then rapidly excreted from the body.